Summary
|
Amend the Principal Regulations
as a consequence of changes made by the Therapeutic
Goods Amendment Act (No. 1) 2003, concerning advertising offences,
pre-approval of advertisements about medicines, procedures of the Complaints
Resolution Panel, and other related matters.
|